Hematology NewsRituximab, bendamustine look better than chemo alone in MCLSeptember 7, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsProgressive myeloma after induction? Go straight to transplantSeptember 6, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersTransplantationTransplant
Hematology NewsIbrutinib-rituximab induction yields ‘unprecedented’ responses in MCLAugust 27, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsCombo produces responses in triple-class refractory myelomaAugust 21, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsObinutuzumab-lenalidomide combo shows promise in relapsed/refractory FLAugust 21, 2019Follicular LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Oncology PracticeBrentuximab vedotin plus nivolumab shows positive outcomes in PMBLAugust 20, 2019B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib/rituximab effective, safe as frontline treatment for older patients with MCLAugust 12, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsHDAC/HMA combo shows ‘remarkable’ activity in PTCLAugust 9, 2019T Cell LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsCardiovascular complications most common with carfilzomib in relapsed myelomaAugust 9, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersPatient & Survivor Care
Hematology NewsLow-dose radiation therapy looks effective in hard-to-treat MCLAugust 7, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsTP53 double hit predicts aggressive myelomaJuly 31, 2019Multiple MyelomaTranslational ResearchLymphoma & Plasma Cell Disorders
Hematology NewsResearchers combine genetic and clinical factors in new VTE risk scoreJuly 31, 2019ThrombosisLymphoma & Plasma Cell Disorders
Oncology PracticeBRCA2 mutations linked to childhood NHLJuly 25, 2019Patient & Survivor CarePediatricsPreventive CareLymphoma & Plasma Cell Disorders
Oncology PracticeLymphoma risk prompts FDA recall of Allergan’s textured breast implantsJuly 24, 2019Lymphoma & Plasma Cell DisordersT Cell Lymphomas
Hematology NewsBTK mutations linked to CLL progression on ibrutinibJuly 24, 2019CLLLymphoma & Plasma Cell DisordersB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
